Results 311 to 320 of about 148,383 (342)
Some of the next articles are maybe not open access.
Pediatric Surgery International, 2012
Hemangiomas are the most common benign soft tissue tumors occurring in 5-10 % of children at around the age of 1 year and of them 10 % are associated with significant morbidity and entail medical attention. In this study, efficacy and adverse effects of the drug propranolol were observed on hemangiomas.Oral propranolol was given to 36 children at a ...
Matiur Rahman +4 more
openaire +3 more sources
Hemangiomas are the most common benign soft tissue tumors occurring in 5-10 % of children at around the age of 1 year and of them 10 % are associated with significant morbidity and entail medical attention. In this study, efficacy and adverse effects of the drug propranolol were observed on hemangiomas.Oral propranolol was given to 36 children at a ...
Matiur Rahman +4 more
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1981
To the Editor.— I found interesting the comprehensive discussions by Martin D. Valentine, MD, and David M. Kornhauser, MD, concerning the modification of the anaphylactic response by propranolol (1981;245:1767). I would like to add to the discussion the possibility of a drug interaction between epinephrine and propranolol.1,2This combination has led ...
openaire +3 more sources
To the Editor.— I found interesting the comprehensive discussions by Martin D. Valentine, MD, and David M. Kornhauser, MD, concerning the modification of the anaphylactic response by propranolol (1981;245:1767). I would like to add to the discussion the possibility of a drug interaction between epinephrine and propranolol.1,2This combination has led ...
openaire +3 more sources
Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade.
JAMA dermatology, 2015IMPORTANCE Patients with stage T2 multilesion angiosarcomas of the scalp and face that are larger than 10 cm demonstrate a 2-year survival rate of 0%. To our knowledge, major therapeutic advances against this disease have not been reported for decades ...
W. Chow +5 more
semanticscholar +1 more source
Annals of Emergency Medicine, 1980
This is a report of a patient who survived a large propranolol overdose, as documented by toxic blood levels. The signs and symptoms were those of profound inotropic and moderate chronotropic cardiotoxicity which failed to respond to parasympatholytics or catecholamines, but subsequently reversed coincident with the administration of glucagon.
M R, Salzberg, E J, Gallagher
openaire +2 more sources
This is a report of a patient who survived a large propranolol overdose, as documented by toxic blood levels. The signs and symptoms were those of profound inotropic and moderate chronotropic cardiotoxicity which failed to respond to parasympatholytics or catecholamines, but subsequently reversed coincident with the administration of glucagon.
M R, Salzberg, E J, Gallagher
openaire +2 more sources
Clinical Pharmacology and Therapeutics, 1983
Eight hypertensive patients who had been followed in an outpatient clinic during long-term therapy with propranolol (40 to 160 mg twice daily) were studied during a 24-hr stay in the ward. The usual oral dose was given and the total and free plasma concentrations were determined during the 24 hr and the urinary excretion of unchanged drug was measured.
Andreasen, F. +4 more
openaire +4 more sources
Eight hypertensive patients who had been followed in an outpatient clinic during long-term therapy with propranolol (40 to 160 mg twice daily) were studied during a 24-hr stay in the ward. The usual oral dose was given and the total and free plasma concentrations were determined during the 24 hr and the urinary excretion of unchanged drug was measured.
Andreasen, F. +4 more
openaire +4 more sources
British Journal of Psychiatry, 1981
SummaryFifty-three hospitalized chronic schizophrenic patients were treated with either propranolol, chlorpromazine or placebo in a double-blind randomized trial for up to three months. Propranolol in a usual dose of 640 mg/day, produced marked cardiovascular effects but no improvement in schizophrenic symptomatology relative to placebo. The effects of
S J Cooper +7 more
openaire +3 more sources
SummaryFifty-three hospitalized chronic schizophrenic patients were treated with either propranolol, chlorpromazine or placebo in a double-blind randomized trial for up to three months. Propranolol in a usual dose of 640 mg/day, produced marked cardiovascular effects but no improvement in schizophrenic symptomatology relative to placebo. The effects of
S J Cooper +7 more
openaire +3 more sources
Substitution of atenolol for propranolol in a case of propranolol- related depression
American Journal of Psychiatry, 1982The authors describe a 62-year-old woman with symptoms of major depression presumed to be secondary to propranolol use. The patient responded poorly to imipramine; however, her symptoms cleared rapidly when atenolol was substituted for propranolol.
P K Shaw, G N McNeil, D S Dock
openaire +3 more sources